WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.
WDR3 发生相分离,从而介导尼洛替尼治疗骨肉瘤的机制
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03456-x
Li Minglei, Li Nan, Fan Yuying, Zhang Zhan, Zhou Long, Yu Yifan, Ni Man, Tan Mingzi, Huang WanJie, Zhu Tong